22 February 2018

Director/PDMR Dealing

The Company today announces that on 21 February 2018 the following share purchases were made. Malcolm Gillies, Non-Executive Director, purchased 500,000 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") at a purchase price of 3.30p per Ordinary Share; and Hilary Spence, Chief Financial Officer, purchased 30,817 Ordinary Shares at a purchase price of 3.18p.

Following these purchases, Malcolm Gillies holds 4,153,000 Ordinary Shares representing approximately 1.28 per cent of the Company's issued share capital; and Hilary Spence holds 30,817 Ordinary Shares representing approximately 0.01 per cent of the Company's issued share capital.

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Malcolm Gillies
2 Reason for the notification
a) Position/status Non-Executive Director
b) Initial notification / Amendment Initial
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name COLLAGEN SOLUTIONS PLC
b) LEI 213800IFY1CVGRGETL95
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 1p each

ISIN: GB00B94T6Y14
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
3.30p per share 500,000
d) Aggregated information
- Aggregated volume
- Price

N/A - single transaction
e) Date of the transaction 21 February 2018
f) Place of the transaction London Stock Exchange, XLON

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Hilary Spence
2 Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification / Amendment Initial
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name COLLAGEN SOLUTIONS PLC
b) LEI 213800IFY1CVGRGETL95
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

Identification code
Ordinary shares of 1p each

ISIN: GB00B94T6Y14
b) Nature of the transaction Purchase of Ordinary Shares
c) Price(s) and volume(s)
Price(s) Volume(s)
3.18p per share 30,817
d) Aggregated information
- Aggregated volume
- Price

N/A - single transaction
e) Date of the transaction 21 February 2018
f) Place of the transaction London Stock Exchange, XLON

 

Enquiries: 

Collagen Solutions Plc
Jamal Rushdy, Chief Executive Officer
Hilary Spence, Chief Financial Officer
Tel: +44 (0) 141 648 9100
Lisa Baderoon, Head of Investor Relations Tel: +44 (0) 7721 413 496 or lisa.baderoon@collagensolutions.com
   
Cenkos Securities plc (Nominated Adviser and Broker)
Stephen Keys
Steve Cox
Tel: 0207 397 8900
   
Walbrook PR
Anna Dunphy
Helen Cresswell
Tel: +44 (0) 20 7933 8780 or collagen@walbrookpr.com
Mob: +44 (0) 7876 741 001